======= KLF2 ======= == Gene Information == * **Official Symbol**: KLF2 * **Official Name**: Kruppel like factor 2 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=10365|10365]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q9Y5W3|Q9Y5W3]] * **Interactions**: [[https://thebiogrid.org/search.php?search=KLF2&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20KLF2|Open PubMed]] * **OMIM**: [[https://omim.org/entry/602016|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Transcription factor that binds to the CACCC box in the promoter of target genes such as HBB/beta globin or NOV and activates their transcription. {ECO:0000269|PubMed:21063504}. |zf-C2H2| |stress response to acid chemical| |cellular stress response to acid chemical| |cellular response to cycloheximide| |response to cycloheximide| |type I pneumocyte differentiation| |cellular response to laminar fluid shear stress| |response to fungicide| |response to laminar fluid shear stress| |erythrocyte maturation| |cellular response to fluid shear stress| |lung epithelial cell differentiation| |lung cell differentiation| |negative regulation of sprouting angiogenesis| |lung epithelium development| |positive regulation of transcription from RNA polymerase II promoter in response to stress| |erythrocyte development| |response to fluid shear stress| |positive regulation of nitric oxide biosynthetic process| |positive regulation of nitric oxide metabolic process| |negative regulation of interleukin-6 production| |positive regulation of reactive oxygen species biosynthetic process| |regulation of nitric oxide biosynthetic process| |myeloid cell development| |regulation of sprouting angiogenesis| |cellular response to hydrogen peroxide| |erythrocyte differentiation| |multicellular organism growth| |cellular response to alcohol| |regulation of reactive oxygen species biosynthetic process| |erythrocyte homeostasis| |cellular response to ketone| |positive regulation of reactive oxygen species metabolic process| |negative regulation of angiogenesis| |negative regulation of blood vessel morphogenesis| |myeloid cell homeostasis| |negative regulation of vasculature development| |cellular response to antibiotic| |response to hydrogen peroxide| |regulation of transcription from RNA polymerase II promoter in response to stress| |regulation of DNA-templated transcription in response to stress| |cellular response to reactive oxygen species| |anatomical structure maturation| |regulation of interleukin-6 production| |cell maturation| |lung development| |respiratory tube development| |cellular response to interleukin-1| |regulation of reactive oxygen species metabolic process| |response to ketone| |response to reactive oxygen species| |respiratory system development| |response to interleukin-1| |homeostasis of number of cells| |cellular response to acid chemical| |cellular response to toxic substance| |myeloid cell differentiation| |response to alcohol| |regulation of gene expression, epigenetic| |nuclear chromatin| |developmental maturation| |cellular response to oxidative stress| |cellular response to tumor necrosis factor| |response to tumor necrosis factor| |negative regulation of cytokine production| |regulation of angiogenesis| |response to antibiotic| |regulation of vasculature development| |cellular response to peptide| |response to acid chemical| |regulation of neurotransmitter levels| |in utero embryonic development| |response to oxidative stress| |developmental growth| |growth| |cellular response to drug| |response to peptide| |response to toxic substance| |response to inorganic substance| |cellular response to organic cyclic compound| |hemopoiesis| |cellular response to organonitrogen compound| |hematopoietic or lymphoid organ development| |chordate embryonic development| |immune system development| |embryo development ending in birth or egg hatching| |cellular response to nitrogen compound| |DNA-binding transcription factor activity| |epithelial cell differentiation| |regulation of cytokine production| |cell morphogenesis| |cellular component morphogenesis| |tube development| |negative regulation of transcription by RNA polymerase II| |response to organic cyclic compound| |negative regulation of developmental process| |embryo development| |response to organonitrogen compound| |cellular response to cytokine stimulus| |response to drug| |cellular response to oxygen-containing compound| |regulation of anatomical structure morphogenesis| |response to nitrogen compound| |response to cytokine| |epithelium development| |negative regulation of transcription, DNA-templated| |negative regulation of multicellular organismal process| |positive regulation of transcription by RNA polymerase II| |cellular response to endogenous stimulus| |negative regulation of nucleic acid-templated transcription| |negative regulation of RNA biosynthetic process| |negative regulation of RNA metabolic process| |negative regulation of cellular macromolecule biosynthetic process| |negative regulation of nucleobase-containing compound metabolic process| |DNA binding| |negative regulation of macromolecule biosynthetic process| |response to endogenous stimulus| |negative regulation of cellular biosynthetic process| |positive regulation of transcription, DNA-templated| |negative regulation of biosynthetic process| |response to oxygen-containing compound| |DNA-binding transcription factor activity, RNA polymerase II-specific| |positive regulation of nucleic acid-templated transcription| |positive regulation of RNA biosynthetic process| |homeostatic process| |cell development| |cellular response to stress| |positive regulation of protein metabolic process| |negative regulation of gene expression| |positive regulation of RNA metabolic process| |tissue development| |positive regulation of nucleobase-containing compound metabolic process| |positive regulation of macromolecule biosynthetic process| |positive regulation of cellular biosynthetic process| |positive regulation of gene expression| |positive regulation of biosynthetic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp316|Geldanamycin 0.015 to 0.025μM on day4 R07 exp316]]|-1.98| |[[:results:exp269|Bisphenol A 100μM R06 exp269]]|-1.81| |[[:results:exp116|AICAR 240μM R03 exp116]]|-1.78| |[[:results:exp506|Momordin-Ic 10μM R08 exp506]]|1.9| |[[:results:exp524|Staurosporine 0.02μM R08 exp524]]|1.97| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 10785 * **Expression level (log2 read counts)**: 0.08 {{:chemogenomics:nalm6 dist.png?nolink |}}